Main > ONCOLOGY (**) > Thyroid Cancer>DTC>MET>RAI R > TREAT.: > USA. E. c-MET Modulator Tablets>

---

USA. E. c-MET Modulator Tablets>'s subsections
(*) EU CE Mark Date: 2022. 05.03
(*) USA Approval Date: 2021. 09.
>Progressed>2 Prior VEGFR-targeted
Company
Company Licensee EU
DTC: Differentiated Thyroid Cancer
Generic Name: Cabozantinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2022. 07.12
RAI: Radio Active Iodine
RTM
RTM Web-Site

USA. E. c-MET Modulator Tablets>'s products
This section has no products